CMFRI Commercializes Seaweed-Based Nutraceuticals | 22 Dec 2023
The Indian Council of Agricultural Research(ICAR)- Central Marine Fisheries Research Institute (CMFRI) has successfully commercialized two seaweed-based nutraceutical products, CadalminTM Immunalgin extract (CadalminTM IMe) and CadalminTM Antihypercholesterolemic extract (CadalminTM ACe).
- These products, developed with eco-friendly 'green' technology, aim to boost anti-viral immunity and combat high cholesterol or dyslipidemia (imbalance of cholesterol).
- The product is positioned as a potential remedy against post-Covid complications, exhibiting antiviral properties against the delta variant of SARS CoV-2.
- Seaweeds, primitive marine algae, lacking roots, stems, and leaves, play a vital role in marine ecosystems.
- Seaweeds offer nutritional benefits and medicinal properties, containing anti-inflammatory and anti-microbial agents with potential cancer-fighting effects.